Improving access to healthy tissue data for research collaboration
Amplifying the Value of HuBMAP Data Through Data Interoperability and Collaboration
This study is all about bringing together different health data to help researchers better understand and improve children's health, making it easier for them to find new discoveries that can benefit kids.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Carnegie-Mellon University NIH-funded |
| Lab location | 1 site (Pittsburgh, United States) |
| Project ID | NIH-10907962 on NIH RePORTER |
What this research studies
This research focuses on enhancing the value of healthy tissue data collected by the Human BioMolecular Atlas Program (HuBMAP) by integrating it with other relevant datasets. The project aims to establish interoperability between these datasets, allowing researchers to compare and analyze data more effectively. By partnering with other data coordination centers, the research will demonstrate how combined datasets can accelerate scientific discoveries related to children's health. This initiative will involve pilot projects that showcase the benefits of data collaboration.
Who could benefit from this research
Good fit: Ideal candidates for this research are children aged 0-11 years who may benefit from enhanced medical research and data-driven insights into their health.
Not a fit: Patients outside the age range of 0-11 years or those with conditions not related to the focus of the HuBMAP data may not receive benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved understanding and treatment of various health conditions in children by providing researchers with better access to comprehensive data.
How similar studies have performed: Other research initiatives have successfully demonstrated the value of data interoperability in enhancing medical research, making this approach promising and not entirely novel.
Where this research is happening
Pittsburgh, United States
- Carnegie-Mellon University — Pittsburgh, United States (Active)
Researchers
- Principal investigator: Blood, Philip D. — Carnegie-Mellon University
- Study coordinator: Blood, Philip D.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.